Evidence map›Paper›PMID 36912146›Full record

ArticleThe EMBO journal2023

Single-cell analysis of lymphatic endothelial cell fate specification and differentiation during zebrafish development.

Lin Grimm, Elizabeth Mason, Hujun Yu, Stefanie Dudczig, Virginia Panara, Tyrone Chen, Neil I Bower, Scott Paterson, Maria Rondon Galeano, Sakurako Kobayashi and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Mycn regulates vascular development through PI3K signaling pathway in zebrafish.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. SHOC2 Is a Novel Cause of Central Conducting Lymphatic Anomaly.American journal of medical genetics. Part A · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Lung Lymphatics in Edema, Inflammation, and Thrombosis.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Endothelial cell transitions in zebrafish vascular development.Development, growth & differentiation · 2024
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Lin Grimm *Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0001-7807-2096
Elizabeth Mason *Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0002-8823-0024
Hujun YuOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Stefanie DudczigOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0003-0048-7261
Virginia PanaraDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-8717-5190
Tyrone ChenOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0002-9207-0385
Neil I BowerDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, QLD, Australia.
Scott PatersonOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Maria Rondon GaleanoOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Sakurako KobayashiOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0002-9527-2791
Anne SenabouthDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, QLD, Australia.ORCID 0000-0002-8798-9821
Anne K LagendijkDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, QLD, Australia.ORCID 0000-0003-1246-1608
Joseph PowellDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, QLD, Australia.
Kelly A SmithDepartment of Anatomy and Physiology, University of Melbourne, Melbourne, VIC, Australia.
Kazuhide S OkudaOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0002-8060-0377
Katarzyna KoltowskaDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-6841-8900
Benjamin M HoganOrganogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0002-0651-7065
The University of Melbourne · AUThe University of Queensland · AUGarvan Institute of Medical Research · AUUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During development, the lymphatic vasculature forms as a second network derived chiefly from blood vessels. The transdifferentiation of embryonic venous endothelial cells (VECs) into lymphatic endothelial cells (LECs) is a key step in this process. Specification, differentiation and maintenance of LEC fate are all driven by the transcription factor Prox1, yet the downstream mechanisms remain to be elucidated. We here present a single-cell transcriptomic atlas of lymphangiogenesis in zebrafish, revealing new markers and hallmarks of LEC differentiation over four developmental stages. We further profile single-cell transcriptomic and chromatin accessibility changes in zygotic prox1a mutants that are undergoing a LEC-VEC fate shift. Using maternal and zygotic prox1a/prox1b mutants, we determine the earliest transcriptomic changes directed by Prox1 during LEC specification. This work altogether reveals new downstream targets and regulatory regions of the genome controlled by Prox1 and presents evidence that Prox1 specifies LEC fate primarily by limiting blood vascular and haematopoietic fate. This extensive single-cell resource provides new mechanistic insights into the enigmatic role of Prox1 and the control of LEC differentiation in development.

Indexed as

Lymphatic VesselsZebrafishAnimalsCell DifferentiationCells, CulturedEndothelial CellsHomeodomain ProteinsLymphangiogenesisSingle-Cell AnalysisTranscription FactorsTumor Suppressor ProteinsHomeodomain ProteinsTranscription FactorsTumor Suppressor ProteinslymphangiogenesislymphaticsNotch1Prox1Vegfc single-cell sequencing

Identifiers

PMID36912146
PMCPMC10233382
OpenAlexW4324020767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.